DE60315984D1 - Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung - Google Patents

Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung

Info

Publication number: DE60315984D1
Authority: DE; Germany
Prior art keywords: hammender; benzoxoxolsulfonamides; protease; broad; substituted
Prior art date: 2002-05-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60315984T

Other languages

English (en)

Other versions

DE60315984T2 (de

Inventor

Dominique Louis Surleraux

Bernhard Joanna Vergouwen

Kock Herman Augustinus De

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Janssen R&D Ireland ULC

Original Assignee

Tibotec Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-17

Filing date

2003-05-16

Publication date

2007-10-11

2003-05-16 Application filed by Tibotec Pharmaceuticals Ltd filed Critical Tibotec Pharmaceuticals Ltd

2007-10-11 Application granted granted Critical

2007-10-11 Publication of DE60315984D1 publication Critical patent/DE60315984D1/de

2008-05-29 Publication of DE60315984T2 publication Critical patent/DE60315984T2/de

2023-05-17 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE60315984T 2002-05-17 2003-05-16 Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung Expired - Lifetime DE60315984T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP02076957		2002-05-17
EP02076957		2002-05-17
PCT/EP2003/050173 WO2003097616A1 (en)	2002-05-17	2003-05-16	Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors

Publications (2)

Publication Number	Publication Date
DE60315984D1 true DE60315984D1 (de)	2007-10-11
DE60315984T2 DE60315984T2 (de)	2008-05-29

Family

ID=29433159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60315984T Expired - Lifetime DE60315984T2 (de)	2002-05-17	2003-05-16	Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung

Country Status (28)

Country	Link
US (1)	US7462636B2 (de)
EP (1)	EP1517899B1 (de)
JP (2)	JP4674084B2 (de)
KR (2)	KR20100130234A (de)
CN (1)	CN100582097C (de)
AP (1)	AP2004003190A0 (de)
AR (1)	AR039887A1 (de)
AT (1)	ATE371652T1 (de)
AU (1)	AU2003238074B2 (de)
BR (1)	BR0310089A (de)
CA (1)	CA2485903C (de)
CY (1)	CY1107040T1 (de)
DE (1)	DE60315984T2 (de)
DK (1)	DK1517899T3 (de)
EA (1)	EA010908B1 (de)
ES (1)	ES2292976T3 (de)
HR (1)	HRP20050607B1 (de)
IL (1)	IL165043A0 (de)
MX (1)	MXPA04011466A (de)
MY (1)	MY135226A (de)
NO (1)	NO330184B1 (de)
NZ (1)	NZ536496A (de)
PL (1)	PL373425A1 (de)
PT (1)	PT1517899E (de)
SI (1)	SI1517899T1 (de)
TW (1)	TWI356700B (de)
WO (1)	WO2003097616A1 (de)
ZA (1)	ZA200410156B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL165043A0 (en) *	2002-05-17	2005-12-18	Tibotec Pharm Ltd	broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
US7807845B2 (en) *	2004-03-11	2010-10-05	Sequoia Pharmaceuticals, Inc.	Resistance-repellent retroviral protease inhibitors
CA2566340C (en) *	2004-05-07	2014-05-06	Sequoia Pharmaceuticals, Inc.	Resistance-repellent retroviral protease inhibitors
PT1856125E (pt)	2005-02-25	2009-11-06	Tibotec Pharm Ltd	Síntese de precursor de inibidor de proteases
EP2139883A4 (de) *	2007-03-23	2011-06-22	Univ Massachusetts	Hiv-1-proteasehemmer
EP2170289B1 (de) *	2008-03-25	2012-02-15	Formac Pharmaceuticals N.v.	Herstellungsverfahren für feststoffdispersionen
WO2011061590A1 (en)	2009-11-17	2011-05-26	Hetero Research Foundation	Novel carboxamide derivatives as hiv inhibitors
DE102010004957A1 (de) *	2010-01-14	2011-07-21	Universitätsklinikum Jena, 07743	Biologisch wirksame Moleküle zur Beeinflussung von Virus-, Bakterien-, Parasiten-infizierten Zellen und/oder Tumorzellen und Verfahren zu deren Anwendung
BR112015009751A2 (pt)	2012-10-31	2017-07-11	Bayer Cropscience Ag	novos compostos heterocíclicos como pesticidas
CN105025887B (zh) *	2013-03-07	2017-07-28	陶氏环球技术有限责任公司	新颖极低粘度酯化纤维素醚

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5004751A (en) *	1987-08-28	1991-04-02	Mochida Pharmaceutical Co., Ltd.	Hydantoin derivatives
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
ES2177868T3 (es) *	1992-08-25	2002-12-16	Searle & Co	Hidroxietilaminosulfonamidas de alfa- y beta-aminoacidos utiles como inhibidores de proteasas retroviricas.
PH30929A (en)	1992-09-03	1997-12-23	Janssen Pharmaceutica Nv	Beads having a core coated with an antifungal and a polymer.
IS2334B (is) *	1992-09-08	2008-02-15	Vertex Pharmaceuticals Inc., (A Massachusetts Corporation)	Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
EP0715618B1 (de)	1993-08-24	1998-12-16	G.D. Searle & Co.	Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
PT721331E (pt)	1993-10-01	2002-05-31	Astrazeneca Ab	Processo i
ATE382041T1 (de) *	1995-01-20	2008-01-15	Searle Llc	Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen
US5756533A (en) *	1995-03-10	1998-05-26	G.D. Searle & Co.	Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) *	1995-03-10	1998-01-06	G.D. Searle & Co.	Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
CN1530372A (zh)	1995-03-10	2004-09-22	G.D.ɪ��˾	杂环羰基氨基酸羟乙氨基磺酰胺逆转录病毒蛋白酶抑制剂
US6150556A (en)	1995-03-10	2000-11-21	G. D. Dearle & Co.	Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
AU7722296A (en)	1995-11-15	1997-06-05	G.D. Searle & Co.	Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
IL124935A (en)	1996-05-20	2001-06-14	Janssen Pharmaceutica Nv	Dispersible antifungal compositions comprising itraconazole with improved bioavailability
EP0969821B1 (de)	1997-03-26	2003-06-04	Janssen Pharmaceutica N.V.	Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist
AU2012199A (en)	1997-12-24	1999-07-19	Vertex Pharmaceuticals Incorporated	Prodrugs of aspartyl protease inhibitors
US6436989B1 (en)	1997-12-24	2002-08-20	Vertex Pharmaceuticals, Incorporated	Prodrugs of aspartyl protease inhibitors
BR9814484A (pt)	1997-12-24	2000-10-10	Vertex Pharma	"pró-drogas de inibidores de aspartil protease"
WO1999033792A2 (en)	1997-12-24	1999-07-08	Vertex Pharmaceuticals Incorporated	Prodrugs os aspartyl protease inhibitors
AU4828199A (en)	1998-06-23	2000-01-10	Board Of Trustees Of The University Of Illinois, The	Multi-drug resistant retroviral protease inhibitors and associated methods
CA2336160C (en) *	1998-06-23	2015-02-17	The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Use of compounds for treating hiv
ATE398623T1 (de)	1999-10-06	2008-07-15	Tibotec Pharm Ltd	Hexahydrofuro-2,3-b furan-3-yl-n- 3-,(1,3- benzodioxol-5-ylsulfonyl)(isobutyl)amino -1- benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer
CN100491360C (zh) *	2001-04-09	2009-05-27	泰博特克药品有限公司	广谱2-(取代的-氨基)-苯并唑磺酰胺hiv蛋白酶抑制剂
IL165043A0 (en) *	2002-05-17	2005-12-18	Tibotec Pharm Ltd	broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors

2003
- 2003-05-16 IL IL16504303A patent/IL165043A0/xx not_active IP Right Cessation
- 2003-05-16 EP EP03735707A patent/EP1517899B1/de not_active Expired - Lifetime
- 2003-05-16 KR KR1020107025714A patent/KR20100130234A/ko not_active Withdrawn
- 2003-05-16 DE DE60315984T patent/DE60315984T2/de not_active Expired - Lifetime
- 2003-05-16 NZ NZ536496A patent/NZ536496A/en not_active IP Right Cessation
- 2003-05-16 DK DK03735707T patent/DK1517899T3/da active
- 2003-05-16 WO PCT/EP2003/050173 patent/WO2003097616A1/en not_active Ceased
- 2003-05-16 PT PT03735707T patent/PT1517899E/pt unknown
- 2003-05-16 CN CN03816458A patent/CN100582097C/zh not_active Expired - Fee Related
- 2003-05-16 SI SI200331012T patent/SI1517899T1/sl unknown
- 2003-05-16 EA EA200401524A patent/EA010908B1/ru not_active IP Right Cessation
- 2003-05-16 PL PL03373425A patent/PL373425A1/xx unknown
- 2003-05-16 TW TW092113367A patent/TWI356700B/zh not_active IP Right Cessation
- 2003-05-16 CA CA2485903A patent/CA2485903C/en not_active Expired - Fee Related
- 2003-05-16 HR HRP20050607AA patent/HRP20050607B1/hr not_active IP Right Cessation
- 2003-05-16 ES ES03735707T patent/ES2292976T3/es not_active Expired - Lifetime
- 2003-05-16 AT AT03735707T patent/ATE371652T1/de active
- 2003-05-16 MY MYPI20031819A patent/MY135226A/en unknown
- 2003-05-16 BR BR0310089-8A patent/BR0310089A/pt not_active IP Right Cessation
- 2003-05-16 AU AU2003238074A patent/AU2003238074B2/en not_active Ceased
- 2003-05-16 AP AP2004003190A patent/AP2004003190A0/xx unknown
- 2003-05-16 KR KR1020047018261A patent/KR101019648B1/ko not_active Expired - Fee Related
- 2003-05-16 AR ARP030101725A patent/AR039887A1/es active IP Right Grant
- 2003-05-16 JP JP2004505349A patent/JP4674084B2/ja not_active Expired - Fee Related
- 2003-05-16 US US10/514,539 patent/US7462636B2/en not_active Expired - Fee Related
- 2003-05-16 MX MXPA04011466A patent/MXPA04011466A/es active IP Right Grant
2004
- 2004-12-14 NO NO20045444A patent/NO330184B1/no not_active IP Right Cessation
- 2004-12-15 ZA ZA2004/10156A patent/ZA200410156B/en unknown
2007
- 2007-11-29 CY CY20071101524T patent/CY1107040T1/el unknown
2010
- 2010-10-25 JP JP2010238833A patent/JP2011051999A/ja active Pending

Also Published As

Publication number	Publication date
BR0310089A (pt)	2005-02-15
AP2004003190A0 (en)	2004-12-31
EA010908B1 (ru)	2008-12-30
EP1517899B1 (de)	2007-08-29
NO20045444L (no)	2005-02-16
KR101019648B1 (ko)	2011-03-07
US20050171173A1 (en)	2005-08-04
EA200401524A1 (ru)	2005-06-30
WO2003097616A1 (en)	2003-11-27
TWI356700B (en)	2012-01-21
ZA200410156B (en)	2005-11-30
JP2005527607A (ja)	2005-09-15
MY135226A (en)	2008-02-29
HK1076099A1 (en)	2006-01-06
JP2011051999A (ja)	2011-03-17
CA2485903A1 (en)	2003-11-27
US7462636B2 (en)	2008-12-09
EP1517899A1 (de)	2005-03-30
PT1517899E (pt)	2007-11-16
HRP20050607A2 (en)	2006-02-28
CN1668605A (zh)	2005-09-14
PL373425A1 (en)	2005-08-22
KR20100130234A (ko)	2010-12-10
TW200404538A (en)	2004-04-01
SI1517899T1 (sl)	2008-02-29
NO330184B1 (no)	2011-02-28
CY1107040T1 (el)	2012-09-26
AU2003238074B2 (en)	2009-04-30
DE60315984T2 (de)	2008-05-29
IL165043A0 (en)	2005-12-18
ES2292976T3 (es)	2008-03-16
CA2485903C (en)	2011-08-16
HRP20050607B1 (hr)	2014-07-04
NZ536496A (en)	2006-06-30
DK1517899T3 (da)	2007-12-03
CN100582097C (zh)	2010-01-20
AU2003238074A1 (en)	2003-12-02
AR039887A1 (es)	2005-03-09
KR20050013549A (ko)	2005-02-04
MXPA04011466A (es)	2005-02-14
ATE371652T1 (de)	2007-09-15
JP4674084B2 (ja)	2011-04-20

Publication	Publication Date	Title
DE60332125D1 (de)	2010-05-27	Indole mit antidiabetischer wirkung
DE602004029705D1 (de)	2010-12-02	5,7-diaminopyrazoloä4,3-düpyrimidine mit pde-5-hemmender wirkung
DE60336335D1 (de)	2011-04-21	Photochromischer gegenstand
ATE390423T1 (de)	2008-04-15	Benzoazolylpiperazinderivate mit vr1- antagonistischer wirkung
EP1557594A4 (de)	2006-01-18	Ölring
NO20044046L (no)	2004-11-15	Substituerte hydroksyetylaminer
ATE318817T1 (de)	2006-03-15	Aza-arylpiperazine
DE60326590D1 (de)	2009-04-23	Tend lamotrigin
ATE349458T1 (de)	2007-01-15	Etonogestrelester
ATE361282T1 (de)	2007-05-15	Indazol-aminoacetonitrilderivate mit pestizider wirkung
ATE496887T1 (de)	2011-02-15	Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
ATE446750T1 (de)	2009-11-15	3-cyano-chinolin-derivate mit antiproliferativer wirkung
DE60315984D1 (de)	2007-10-11	Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
DE602004027792D1 (de)	2010-08-05	Indazolamide mit analgetischer wirkung
ATA4142004A (de)	2005-12-15	Trägerverbau
ATE444953T1 (de)	2009-10-15	Substituierte spirobenzazepine
DE602004017199D1 (de)	2008-11-27	Silikonverbindungen mit mikrobizider wirkung
DE502004009935D1 (de)	2009-10-01	Substituierte dihydrochinazoline ii
DE60330246D1 (de)	2010-01-07	Geschenkverpackung
DE50311770D1 (de)	2009-09-17	Oberfräse
SE0500656L (sv)	2005-03-23	Spridare
ATE396192T1 (de)	2008-06-15	N-sulfonylaminothiazole
IS2316B (is)	2007-11-15	Stöðugt rotvarnarefni
DE50306228D1 (de)	2007-02-15	Substituierte benzdioxepine
ATA16872002A (de)	2005-06-15	Zwischenstück

Legal Events

Date	Code	Title	Description
2008-09-18	8364	No opposition during term of opposition